RadioClash is the future of enhanced electroporation therapy
A revolutionary new treatment for cancer of the liver, pancreas, and bones. Effective, more affordable, faster recovery, minimally invasive.
A revolutionary new treatment for cancer of the liver, pancreas, and bones. Effective, more affordable, faster recovery, minimally invasive.
RadioClash has partnered with Houston based Biotex. With over 20 years of MedTech expertise, Biotex delivers strategic guidance and a proven track record of success. From development to commercialization, [they] help turn innovative ideas into market-ready medical devices.
RadioClash was the winning company in our medical device pitch cohort. We also won 3rd place in the competition overall, and were the only company developing a medical device that placed in the Top 3.
A premier international medtech and biotech event. RadioClash was the winning company in our medical device pitch cohort for the Innovator's Pitch Competition.
Harvard Business School - Advanced to Semifinals in Atlanta, GA
Advanced to West Coast RoadTour pitch cohort with a successful pitch at UCLA in early March '25. We will receive new if we have made it to the Finals in June.
Interventional Radiology UTHealth / MD Anderson Cancer Center
Electrical Engineer Software & Product Developer
Interventional Radiology UTHealth / MD Anderson Cancer Center
President BioTex, Inc. Partner, MedTex Ventures